精密药物用于与道病相关的自闭症和
Morgan Robinson1, Kyle Wettschurack2, Manasi S Halurkar2
1Borch Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA; Department of Chemical Engineering, College of Engineering, Purdue University, West Lafayette, IN, USA; Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA.
Trends in molecular medicine
|October 29, 2025
概括
精准医学正在为由电压导入通道 (VGSC) 基因引起的单一性脑疾病取得进展. 新的基因疗法和疾病模型为治疗严重和自闭症谱系障碍 (ASD) 提供了希望.
科学领域:
- 神经遗传学 神经遗传学
- 分子医学是分子医学.
- 发育神经科学的发展神经科学.
背景情况:
- 单一性脑疾病,特别是严重的和自闭症谱系障碍 (ASD),通常是由电压通道 (VGSC) 基因的突变引起的,包括SCN1A,SCN2A,SCN3A和SCN8A.
- 基因组技术的快速发展为开发针对这些复杂的神经疾病的向治疗铺平了道路.
研究的目的:
- 审查VGSC相关神经系统疾病的疾病建模的最新突破.
- 突出下一代治疗策略,以推进这一领域的精准医学.
主要方法:
- 利用动物模型和人类诱导多能干细胞 (hiPSC) 技术用于疾病建模.
- 研究各种基因编辑和基因调制治疗方法,包括病毒载体基因替代,CRISPR基因编辑,主要编辑,反意义寡核酸,工程tRNA和CRISPR激活/干扰 (CRISPRa/i).
主要成果:
- 人类诱导的多能干细胞 (hiPSC) 疾病模型为研究VGSC相关疾病提供了一个强大的平台.
- 许多基因疗法,包括病毒载体基因替代和基于CRISPR的编辑技术,正在通过VGSC相关疾病的临床前和临床阶段进行进展.
结论:
- 精准医学方法正在快速发展,用于与VGSC基因相关的单一性脑疾病.
- 疾病建模和治疗开发的进步对未来严重和ASD治疗有很大的前景.
相关概念视频
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
806
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
806
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K
01:20Antiepileptic Drugs: Potassium Channel Activators
624
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
624
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K